US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nextcure Inc.

5.91

+0.02000.34%

Post-market: 5.910.00000.00%19:30 EDT

Volume:160.42K

Turnover:1.00M

Market Cap:27.05M

PE:-0.58

High:6.76

Open:5.93

Low:5.84

Close:5.89

52wk High:15.74

52wk Low:1.55

Shares:4.58M

Float Shares:2.94M

Volume Ratio:1.22

T/O Rate:5.47%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-10.2671

EPS(LYR):-19.6464

ROE:-204.56%

ROA:-69.02%

PB:2.23

PE(LYR):-0.30

Loading ...

Overview Company News Filings

Hansoh Pharma Licenses Oral IL-23 Drug Hs-20118 to Avere in Deal Worth up to USD 2.3 Billion

Nextcure Agrees to Merge with Avere Therapeutics in All-stock Deal

Hansoh Pharmaceutical - Avere Therapeutics to Merge into Nextcure Under Merger Agreement Signed July 14, 2026

THOMSON REUTERS

Nextcure - Announces Concurrent $320 Mln Private Placement Led by Fairmount and Hansoh

THOMSON REUTERS

Nextcure Inc: Combined Company Plans to Operate Under Name Avere Therapeutics

THOMSON REUTERS

Nextcure - Andrew Cheng to Serve as CEO, President, and Chairman of Combined Company

THOMSON REUTERS

Nextcure - Combined Company to Operate as Avere Therapeutics, Trade as Avrx After Merger in H2 2026

THOMSON REUTERS

Nextcure - Stockholders to Own 1.21%, Avere Stockholders 98.79% of Combined Company at Closing

THOMSON REUTERS

Nextcure and Avere Therapeutics Announce Merger to Advance Once-weekly Oral Il-23 Therapy

THOMSON REUTERS

Nextcure - Stockholders to Receive CVR for 90% of Net Proceeds from Pipeline Monetization for Two Years Post-closing

THOMSON REUTERS

Nextcure - Avere to Pay Hansoh $120 Mln Upfront, up to $2.18 Bln in Milestones, Plus Royalties for Avr-1 Ex-china Rights

THOMSON REUTERS

Press Release: Nextcure and Avere Therapeutics Announce Merger to Advance Once-weekly Oral IL-23 Therapy

Nextcure Shareholders Approve Amended 2019 Incentive Plan Adding 80,000 Shares

NextCure posts Phase 1 dose-escalation data for SIM0505 in ovarian, uterine serous cancers at ASCO 2026

Nxtc Announces Replay Available for Virtual Kol Event Discussing Asco 2026 Dose Escalation Data From Phase 1 Trial of Sim0505 for Gynecologic Cancers

THOMSON REUTERS

NextCure posts Phase 1 SIM0505 dose-escalation presentation slides

NextCure share weakness overdone, says Lucid Capital

NextCure presents Phase 1 data for SIM0505 in gynecologic cancers

NextCure posts corporate presentation highlighting SIM0505 CDH6-targeting ADC program in cancer

NextCure reports 55% response rate in Phase 1 SIM0505 trial in gynecologic cancers at ASCO 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/NXTC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NXTC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXTC\",,,,,undefined,":{"symbol":"NXTC","market":"US","secType":"STK","nameCN":"Nextcure Inc.","latestPrice":5.91,"timestamp":1787688000000,"preClose":5.89,"halted":0,"volume":160415,"hourTrading":{"tag":"盘后","latestPrice":5.91,"preClose":5.91,"latestTime":"19:30 EDT","volume":34,"amount":200.46,"timestamp":1787700602069,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0033955857385399766,"floatShares":2935000,"shares":4577400,"eps":-10.2671,"marketStatus":"Closed","change":0.02,"latestTime":"08-25 16:00:00 EDT","open":5.93,"high":6.7594,"low":5.84,"amount":1003620.6466225,"amplitude":0.156095,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.2671,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":5.89,"preHourTrading":{"tag":"盘前","latestPrice":6.12,"preClose":5.89,"latestTime":"09:27 EDT","volume":149,"amount":901.063494,"timestamp":1787664452457,"change":0.23,"changeRate":0.039049,"amplitude":0.026978},"postHourTrading":{"tag":"盘后","latestPrice":5.91,"preClose":5.91,"latestTime":"19:30 EDT","volume":34,"amount":200.46,"timestamp":1787700602069,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.216426,"impliedVol":0.7756,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXTC\",,,,,undefined,":{"symbol":"NXTC","floatShares":2935000,"roa":"-69.02%","roe":"-204.56%","lyrEps":-19.646445,"volumeRatio":1.216426,"shares":4577400,"dividePrice":0,"high":6.7594,"amplitude":0.156095,"preClose":5.89,"low":5.84,"week52Low":1.55,"pbRate":"2.23","week52High":15.7399,"institutionHeld":0,"latestPrice":5.91,"eps":-10.2671,"divideRate":0,"volume":160415,"delay":0,"ttmEps":-10.2671,"open":5.93,"prevYearClose":14.19,"prevWeekClose":6.29,"prevMonthClose":4.145,"prevQuarterClose":1.6,"fiveDayClose":6.65,"twentyDayClose":5.42,"sixtyDayClose":6.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NXTC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"NXTC","fiscalQuarterEnding":"2026/06","expectedEps":-1.98,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.84},{"market":"US","date":"2026-05-07","symbol":"NXTC","fiscalQuarterEnding":"2026/03","expectedEps":-1.85,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-1.87},{"market":"US","date":"2026-03-05","symbol":"NXTC","fiscalQuarterEnding":"2025/12","expectedEps":-2.26,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2025-11-05","symbol":"NXTC","fiscalQuarterEnding":"2025/09","expectedEps":-4.06,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":-3.22},{"market":"US","date":"2025-08-07","symbol":"NXTC","fiscalQuarterEnding":"2025/06","expectedEps":-4.62,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-11.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NXTC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NXTC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1762747200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NXTC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NXTC","date":"2026-08-24","current":-0.596079,"percent":0.423686,"low":-3.787079,"twenty":-1.534632,"median":-0.630015,"eighty":-0.393839,"high":-0.105725,"avg":-0.91698,"sd":0.769005,"marketCap":28791588},"quantilePoints":[{"date":"2021-08-27","current":-3.087926,"twenty":-33.313366,"median":-14.54037,"eighty":-8.596004,"marketCap":204877738},{"date":"2021-09-03","current":-3.221098,"twenty":-33.275794,"median":-14.353002,"eighty":-8.480121,"marketCap":213713435},{"date":"2021-09-10","current":-3.008855,"twenty":-33.23598,"median":-14.322168,"eighty":-8.271766,"marketCap":199631542},{"date":"2021-09-17","current":-2.913138,"twenty":-33.053529,"median":-14.252792,"eighty":-7.645917,"marketCap":193280885},{"date":"2021-09-24","current":-2.933946,"twenty":-33.005428,"median":-14.202654,"eighty":-7.51019,"marketCap":194661462},{"date":"2021-10-01","current":-3.146189,"twenty":-32.890386,"median":-14.0755,"eighty":-7.344302,"marketCap":208743355},{"date":"2021-10-08","current":-3.171159,"twenty":-32.869789,"median":-13.861335,"eighty":-7.118092,"marketCap":210400049},{"date":"2021-10-15","current":-3.633099,"twenty":-32.860746,"median":-13.744915,"eighty":-6.974825,"marketCap":241048875},{"date":"2021-10-22","current":-3.441665,"twenty":-32.779509,"median":-13.705498,"eighty":-6.816478,"marketCap":228347559},{"date":"2021-10-29","current":-3.420856,"twenty":-32.730233,"median":-13.510535,"eighty":-6.034448,"marketCap":226966982},{"date":"2021-11-05","current":-3.502552,"twenty":-32.66811,"median":-13.207877,"eighty":-3.671419,"marketCap":237861814},{"date":"2021-11-12","current":-2.615727,"twenty":-32.637276,"median":-13.133676,"eighty":-3.636286,"marketCap":177636639},{"date":"2021-11-19","current":-2.359443,"twenty":-32.603797,"median":-13.002396,"eighty":-3.614328,"marketCap":160232116},{"date":"2021-11-26","current":-2.448939,"twenty":-32.599568,"median":-12.990981,"eighty":-3.604396,"marketCap":166309886},{"date":"2021-12-03","current":-2.326899,"twenty":-32.562341,"median":-12.814039,"eighty":-3.59237,"marketCap":158022018},{"date":"2021-12-10","current":-2.489619,"twenty":-32.440719,"median":-12.477277,"eighty":-3.574803,"marketCap":169072509},{"date":"2021-12-17","current":-2.379783,"twenty":-32.255361,"median":-11.921142,"eighty":-3.545774,"marketCap":161613427},{"date":"2021-12-23","current":-2.514027,"twenty":-32.089537,"median":-11.883665,"eighty":-3.530886,"marketCap":170730082},{"date":"2021-12-31","current":-2.440803,"twenty":-31.909182,"median":-11.769509,"eighty":-3.517711,"marketCap":165757362},{"date":"2022-01-07","current":-2.294355,"twenty":-31.794602,"median":-11.710643,"eighty":-3.506378,"marketCap":155811920},{"date":"2022-01-14","current":-2.310627,"twenty":-31.648466,"median":-11.598274,"eighty":-3.489605,"marketCap":156916969},{"date":"2022-01-21","current":-2.180451,"twenty":-31.463026,"median":-11.504439,"eighty":-3.473795,"marketCap":148076576},{"date":"2022-01-28","current":-2.184519,"twenty":-31.270312,"median":-11.461384,"eighty":-3.453593,"marketCap":148352838},{"date":"2022-02-04","current":-2.172315,"twenty":-31.190863,"median":-11.27246,"eighty":-3.443977,"marketCap":147524052},{"date":"2022-02-11","current":-2.086886,"twenty":-31.093821,"median":-11.17795,"eighty":-3.412312,"marketCap":141722544},{"date":"2022-02-18","current":-2.09909,"twenty":-31.029239,"median":-10.947584,"eighty":-3.353464,"marketCap":142551331},{"date":"2022-02-25","current":-2.034002,"twenty":-31.012381,"median":-10.919045,"eighty":-3.299185,"marketCap":138131135},{"date":"2022-03-04","current":-1.901853,"twenty":-30.903906,"median":-10.889639,"eighty":-3.262715,"marketCap":131967682},{"date":"2022-03-11","current":-1.961785,"twenty":-30.564854,"median":-10.825686,"eighty":-3.217769,"marketCap":136126327},{"date":"2022-03-18","current":-2.045691,"twenty":-30.468636,"median":-10.808107,"eighty":-3.180314,"marketCap":141948431},{"date":"2022-03-25","current":-2.017722,"twenty":-30.27946,"median":-10.764934,"eighty":-3.171159,"marketCap":140007730},{"date":"2022-04-01","current":-1.981763,"twenty":-30.206073,"median":-10.690732,"eighty":-3.162158,"marketCap":137512542},{"date":"2022-04-08","current":-2.105623,"twenty":-30.113715,"median":-10.627946,"eighty":-3.149121,"marketCap":146107076},{"date":"2022-04-14","current":-2.00174,"twenty":-30.083493,"median":-10.593707,"eighty":-3.137866,"marketCap":138898758},{"date":"2022-04-22","current":-1.869889,"twenty":-30.015267,"median":-10.582284,"eighty":-3.117058,"marketCap":129749738},{"date":"2022-04-29","current":-1.663262,"twenty":-29.933561,"median":-10.576523,"eighty":-3.087926,"marketCap":115412119},{"date":"2022-05-06","current":-1.435368,"twenty":-29.852185,"median":-10.553745,"eighty":-3.075441,"marketCap":105439227},{"date":"2022-05-13","current":-1.337158,"twenty":-29.771616,"median":-10.490605,"eighty":-3.062957,"marketCap":98224964},{"date":"2022-05-20","current":-1.43159,"twenty":-29.770644,"median":-10.475071,"eighty":-3.029664,"marketCap":105161755},{"date":"2022-05-27","current":-1.507136,"twenty":-29.640178,"median":-10.456712,"eighty":-3.000532,"marketCap":110711188},{"date":"2022-06-03","current":-1.575127,"twenty":-29.577676,"median":-10.433881,"eighty":-2.930617,"marketCap":115705678},{"date":"2022-06-10","current":-1.790432,"twenty":-29.513656,"median":-10.370737,"eighty":-2.89233,"marketCap":131521562},{"date":"2022-06-17","current":-1.620454,"twenty":-29.488512,"median":-10.301585,"eighty":-2.863198,"marketCap":119035337},{"date":"2022-06-24","current":-1.756437,"twenty":-29.455895,"median":-10.251231,"eighty":-2.824912,"marketCap":129024317},{"date":"2022-07-01","current":-1.699777,"twenty":-29.392293,"median":-10.19986,"eighty":-2.630372,"marketCap":124862242},{"date":"2022-07-08","current":-1.816873,"twenty":-29.327482,"median":-10.133412,"eighty":-2.540062,"marketCap":133463863},{"date":"2022-07-15","current":-1.726218,"twenty":-29.267353,"median":-10.068581,"eighty":-2.52379,"marketCap":126804544},{"date":"2022-07-22","current":-1.703555,"twenty":-29.221057,"median":-9.983688,"eighty":-2.496128,"marketCap":125139714},{"date":"2022-07-29","current":-1.624232,"twenty":-29.079772,"median":-9.932137,"eighty":-2.464397,"marketCap":119312809},{"date":"2022-08-05","current":-1.780832,"twenty":-28.947368,"median":-9.846219,"eighty":-2.440803,"marketCap":130697055},{"date":"2022-08-12","current":-1.924509,"twenty":-28.936385,"median":-9.811852,"eighty":-2.418022,"marketCap":141241615},{"date":"2022-08-19","current":-1.803518,"twenty":-28.883293,"median":-9.748914,"eighty":-2.374901,"marketCap":132361985},{"date":"2022-08-26","current":-1.663622,"twenty":-28.776985,"median":-9.725934,"eighty":-2.364325,"marketCap":122094913},{"date":"2022-09-02","current":-1.538851,"twenty":-28.698739,"median":-9.559959,"eighty":-2.328526,"marketCap":112937795},{"date":"2022-09-09","current":-1.440546,"twenty":-28.685307,"median":-9.528322,"eighty":-2.312254,"marketCap":105723095},{"date":"2022-09-16","current":-1.463232,"twenty":-28.673616,"median":-9.497799,"eighty":-2.295169,"marketCap":107388026},{"date":"2022-09-23","current":-1.122945,"twenty":-28.646583,"median":-9.444387,"eighty":-2.230894,"marketCap":82414066},{"date":"2022-09-30","current":-1.039764,"twenty":-28.558519,"median":-9.383643,"eighty":-2.193469,"marketCap":76309321},{"date":"2022-10-07","current":-1.145631,"twenty":-28.537743,"median":-9.377244,"eighty":-2.176383,"marketCap":84078997},{"date":"2022-10-14","current":-1.020859,"twenty":-28.513281,"median":-9.350036,"eighty":-2.135702,"marketCap":74921878},{"date":"2022-10-21","current":-0.903649,"twenty":-28.42673,"median":-9.335006,"eighty":-2.100397,"marketCap":66319737},{"date":"2022-10-28","current":-0.949021,"twenty":-28.352993,"median":-9.304935,"eighty":-2.086886,"marketCap":69649598},{"date":"2022-11-04","current":-0.739439,"twenty":-28.262004,"median":-9.197537,"eighty":-2.063915,"marketCap":54993581},{"date":"2022-11-11","current":-0.661014,"twenty":-28.116474,"median":-9.086124,"eighty":-2.04649,"marketCap":49160928},{"date":"2022-11-18","current":-0.556447,"twenty":-28.052158,"median":-9.067704,"eighty":-2.034742,"marketCap":41384058},{"date":"2022-11-25","current":-0.541509,"twenty":-28.027666,"median":-9.029996,"eighty":-2.025866,"marketCap":40273077},{"date":"2022-12-02","current":-0.52657,"twenty":-27.675038,"median":-8.973018,"eighty":-2.009731,"marketCap":39162095},{"date":"2022-12-09","current":-0.504163,"twenty":-27.605334,"median":-8.926895,"eighty":-1.993322,"marketCap":37495623},{"date":"2022-12-16","current":-0.474287,"twenty":-27.600864,"median":-8.882534,"eighty":-1.977767,"marketCap":35273660},{"date":"2022-12-23","current":-0.459349,"twenty":-27.565163,"median":-8.802314,"eighty":-1.962318,"marketCap":34162679},{"date":"2022-12-30","current":-0.52657,"twenty":-27.529121,"median":-8.737875,"eighty":-1.958582,"marketCap":39162095},{"date":"2023-01-06","current":-0.604996,"twenty":-27.456005,"median":-8.69062,"eighty":-1.937028,"marketCap":44994748},{"date":"2023-01-13","current":-0.601261,"twenty":-27.359955,"median":-8.626181,"eighty":-1.90966,"marketCap":44717002},{"date":"2023-01-20","current":-0.646076,"twenty":-27.246132,"median":-8.574631,"eighty":-1.905849,"marketCap":48049947},{"date":"2023-01-27","current":-0.623669,"twenty":-26.955846,"median":-8.480121,"eighty":-1.890112,"marketCap":46383475},{"date":"2023-02-03","current":-0.619934,"twenty":-26.621528,"median":-8.294387,"eighty":-1.855725,"marketCap":46105729},{"date":"2023-02-10","current":-0.634872,"twenty":-26.482469,"median":-7.977692,"eighty":-1.830429,"marketCap":47216711},{"date":"2023-02-17","current":-0.590058,"twenty":-26.415476,"median":-7.645917,"eighty":-1.805709,"marketCap":43883766},{"date":"2023-02-24","current":-0.593792,"twenty":-26.370562,"median":-7.547892,"eighty":-1.802115,"marketCap":44161512},{"date":"2023-03-03","current":-0.557475,"twenty":-26.343023,"median":-7.461178,"eighty":-1.784389,"marketCap":41661804},{"date":"2023-03-10","current":-0.553759,"twenty":-26.293765,"median":-7.344302,"eighty":-1.767869,"marketCap":41384058},{"date":"2023-03-17","current":-0.59464,"twenty":-26.246562,"median":-7.208576,"eighty":-1.729995,"marketCap":44439257},{"date":"2023-03-24","current":-0.579774,"twenty":-26.136983,"median":-7.118092,"eighty":-1.711864,"marketCap":43328276},{"date":"2023-03-31","current":-0.550042,"twenty":-26.104953,"median":-7.050229,"eighty":-1.703887,"marketCap":41106313},{"date":"2023-04-06","current":-0.546326,"twenty":-26.003804,"median":-6.933353,"eighty":-1.701432,"marketCap":40828567},{"date":"2023-04-14","current":-0.5742,"twenty":-25.708785,"median":-6.831559,"eighty":-1.688445,"marketCap":42911658},{"date":"2023-04-21","current":-0.576058,"twenty":-25.430624,"median":-6.685709,"eighty":-1.663262,"marketCap":43050530},{"date":"2023-04-28","current":-0.561192,"twenty":-25.396908,"median":-6.034448,"eighty":-1.639341,"marketCap":41939549},{"date":"2023-05-05","current":-0.591934,"twenty":-25.144034,"median":-3.755599,"eighty":-1.624232,"marketCap":44237008},{"date":"2023-05-12","current":-0.705187,"twenty":-25.135605,"median":-3.667028,"eighty":-1.620454,"marketCap":49523192},{"date":"2023-05-19","current":-0.704642,"twenty":-25.08503,"median":-3.66044,"eighty":-1.620454,"marketCap":49484904},{"date":"2023-05-22","current":-0.713441,"twenty":-25.034456,"median":-3.653853,"eighty":-1.616864,"marketCap":50102839},{"date":"2023-06-09","current":-0.701551,"twenty":-24.933307,"median":-3.649461,"eighty":-1.591082,"marketCap":49267792},{"date":"2023-06-15","current":-0.642097,"twenty":-24.710778,"median":-3.636286,"eighty":-1.5824,"marketCap":45092555},{"date":"2023-06-30","current":-0.713441,"twenty":-24.538824,"median":-3.634692,"eighty":-1.577253,"marketCap":50102839},{"date":"2023-07-07","current":-0.709478,"twenty":-23.845136,"median":-3.624776,"eighty":-1.54112,"marketCap":49824490},{"date":"2023-07-21","current":-0.709478,"twenty":-23.117786,"median":-3.614328,"eighty":-1.50226,"marketCap":49824490},{"date":"2023-07-28","current":-0.681733,"twenty":-23.046872,"median":-3.602675,"eighty":-1.463703,"marketCap":47876046},{"date":"2023-08-04","current":-0.681733,"twenty":-23.006412,"median":-3.59237,"eighty":-1.440546,"marketCap":47876046},{"date":"2023-08-11","current":-0.686417,"twenty":-22.947409,"median":-3.589846,"eighty":-1.432346,"marketCap":48163144},{"date":"2023-08-18","current":-0.642772,"twenty":-22.917064,"median":-3.574803,"eighty":-1.372977,"marketCap":45100748},{"date":"2023-08-25","current":-0.61103,"twenty":-22.873232,"median":-3.566382,"eighty":-1.367642,"marketCap":42873550},{"date":"2023-09-01","current":-0.579288,"twenty":-22.836144,"median":-3.53967,"eighty":-1.334136,"marketCap":40646353},{"date":"2023-09-08","current":-0.575321,"twenty":-22.741738,"median":-3.530886,"eighty":-1.280499,"marketCap":40367953},{"date":"2023-09-15","current":-0.547547,"twenty":-22.669256,"median":-3.524299,"eighty":-1.145631,"marketCap":38419155},{"date":"2023-09-22","current":-0.531676,"twenty":-22.63216,"median":-3.517711,"eighty":-1.111602,"marketCap":37305557},{"date":"2023-09-29","current":-0.511837,"twenty":-22.606872,"median":-3.511124,"eighty":-1.06245,"marketCap":35913558},{"date":"2023-10-06","current":-0.499934,"twenty":-22.573156,"median":-3.495753,"eighty":-1.039764,"marketCap":35078359},{"date":"2023-10-13","current":-0.491998,"twenty":-22.514152,"median":-3.489166,"eighty":-1.017078,"marketCap":34521560},{"date":"2023-10-20","current":-0.519773,"twenty":-22.505723,"median":-3.473795,"eighty":-0.956583,"marketCap":36470358},{"date":"2023-10-27","current":-0.412644,"twenty":-22.45852,"median":-3.473795,"eighty":-0.946752,"marketCap":28953566},{"date":"2023-11-03","current":-0.464224,"twenty":-22.343884,"median":-3.458424,"eighty":-0.937493,"marketCap":32572762},{"date":"2023-11-10","current":-0.455431,"twenty":-22.193846,"median":-3.449988,"eighty":-0.733353,"marketCap":29856238},{"date":"2023-11-17","current":-0.497995,"twenty":-22.043808,"median":-3.444555,"eighty":-0.713441,"marketCap":32646541},{"date":"2023-11-24","current":-0.536302,"twenty":-21.990775,"median":-3.420975,"eighty":-0.709478,"marketCap":35157814},{"date":"2023-12-01","current":-0.502251,"twenty":-21.915966,"median":-3.412312,"eighty":-0.704751,"marketCap":32925571},{"date":"2023-12-08","current":-0.532046,"twenty":-21.898827,"median":-3.379374,"eighty":-0.697587,"marketCap":34878783},{"date":"2023-12-15","current":-0.497995,"twenty":-21.888712,"median":-3.327628,"eighty":-0.693366,"marketCap":32646541},{"date":"2023-12-22","current":-0.476713,"twenty":-21.839823,"median":-3.284954,"eighty":-0.68402,"marketCap":31251390},{"date":"2023-12-29","current":-0.489482,"twenty":-21.814536,"median":-3.2752,"eighty":-0.681733,"marketCap":32088481},{"date":"2024-01-05","current":-0.510764,"twenty":-21.779134,"median":-3.262715,"eighty":-0.679782,"marketCap":33483632},{"date":"2024-01-12","current":-0.497995,"twenty":-21.725188,"median":-3.241038,"eighty":-0.674514,"marketCap":32646541},{"date":"2024-01-19","current":-0.489482,"twenty":-21.681649,"median":-3.216937,"eighty":-0.673806,"marketCap":32088481},{"date":"2024-01-26","current":-0.506507,"twenty":-21.57632,"median":-3.183644,"eighty":-0.658026,"marketCap":33204602},{"date":"2024-02-02","current":-0.553327,"twenty":-21.441436,"median":-3.179482,"eighty":-0.643433,"marketCap":36273935},{"date":"2024-02-09","current":-0.553327,"twenty":-21.090872,"median":-3.171159,"eighty":-0.639246,"marketCap":36273935},{"date":"2024-02-16","current":-0.600147,"twenty":-21.055916,"median":-3.170771,"eighty":-0.634872,"marketCap":39343268},{"date":"2024-02-23","current":-0.646967,"twenty":-20.988483,"median":-3.161988,"eighty":-0.634872,"marketCap":42412601},{"date":"2024-03-01","current":-0.736351,"twenty":-20.905775,"median":-3.156169,"eighty":-0.634872,"marketCap":48272236},{"date":"2024-03-08","current":-0.7023,"twenty":-20.829927,"median":-3.146189,"eighty":-0.634872,"marketCap":46039994},{"date":"2024-03-15","current":-0.625686,"twenty":-20.53714,"median":-3.136752,"eighty":-0.634872,"marketCap":41017449},{"date":"2024-03-22","current":-0.747367,"twenty":-20.432162,"median":-3.118071,"eighty":-0.631138,"marketCap":46877085},{"date":"2024-03-28","current":-0.860806,"twenty":-20.43181,"median":-3.100505,"eighty":-0.631672,"marketCap":53992357},{"date":"2024-04-05","current":-0.9609,"twenty":-20.149891,"median":-3.087926,"eighty":-0.634259,"marketCap":60270538},{"date":"2024-04-12","current":-0.836339,"twenty":-19.944111,"median":-3.078546,"eighty":-0.634872,"marketCap":52457690},{"date":"2024-04-19","current":-0.700191,"twenty":-19.91028,"median":-3.074798,"eighty":-0.634872,"marketCap":43918063},{"date":"2024-04-26","current":-0.575316,"twenty":-19.842002,"median":-3.07128,"eighty":-0.634872,"marketCap":36085542},{"date":"2024-05-03","current":-0.664512,"twenty":-19.805649,"median":-3.045609,"eighty":-0.631672,"marketCap":41680200},{"date":"2024-05-10","current":-0.75492,"twenty":-19.788888,"median":-3.029664,"eighty":-0.633645,"marketCap":48114057},{"date":"2024-05-17","current":-0.724196,"twenty":-19.653566,"median":-2.983885,"eighty":-0.633645,"marketCap":46155926},{"date":"2024-05-24","current":-0.70664,"twenty":-18.732713,"median":-2.902734,"eighty":-0.633645,"marketCap":45036995},{"date":"2024-05-31","current":-0.693473,"twenty":-18.26814,"median":-2.86736,"eighty":-0.633645,"marketCap":44197796},{"date":"2024-06-07","current":-0.539855,"twenty":-18.148679,"median":-2.761182,"eighty":-0.627403,"marketCap":34407145},{"date":"2024-06-14","current":-0.702251,"twenty":-18.173329,"median":-2.562843,"eighty":-0.627403,"marketCap":44757262},{"date":"2024-06-21","current":-0.65836,"twenty":-18.19798,"median":-2.526231,"eighty":-0.627403,"marketCap":41959933},{"date":"2024-06-28","current":-0.719807,"twenty":-18.26814,"median":-2.514027,"eighty":-0.627343,"marketCap":45876193},{"date":"2024-07-05","current":-0.689084,"twenty":-18.26814,"median":-2.489619,"eighty":-0.627343,"marketCap":43918063},{"date":"2024-07-12","current":-0.700056,"twenty":-18.26814,"median":-2.440803,"eighty":-0.627343,"marketCap":44617395},{"date":"2024-07-15","current":-0.724196,"twenty":-18.26814,"median":-2.440803,"eighty":-0.627343,"marketCap":46155926},{"date":"2024-08-02","current":-0.70664,"twenty":-14.460919,"median":-2.375715,"eighty":-0.625686,"marketCap":45036995},{"date":"2024-08-09","current":-0.71219,"twenty":-14.245084,"median":-2.353341,"eighty":-0.625686,"marketCap":43642310},{"date":"2024-08-16","current":-0.71219,"twenty":-13.890499,"median":-2.320797,"eighty":-0.625686,"marketCap":43642310},{"date":"2024-08-23","current":-0.721321,"twenty":-13.207877,"median":-2.296389,"eighty":-0.625686,"marketCap":44201827},{"date":"2024-08-30","current":-0.716756,"twenty":-13.002396,"median":-2.223165,"eighty":-0.625686,"marketCap":43922068},{"date":"2024-09-06","current":-0.657406,"twenty":-12.819746,"median":-2.186553,"eighty":-0.625686,"marketCap":40285209},{"date":"2024-09-13","current":-0.630015,"twenty":-11.925438,"median":-2.170281,"eighty":-0.623669,"marketCap":38606659},{"date":"2024-09-20","current":-0.652841,"twenty":-11.769509,"median":-2.105623,"eighty":-0.623669,"marketCap":40005451},{"date":"2024-09-27","current":-0.64371,"twenty":-11.598274,"median":-2.086886,"eighty":-0.623669,"marketCap":39445934},{"date":"2024-10-04","current":-0.598057,"twenty":-11.461287,"median":-2.062478,"eighty":-0.621429,"marketCap":36648350},{"date":"2024-10-11","current":-0.630015,"twenty":-11.143583,"median":-2.043693,"eighty":-0.618966,"marketCap":38606659},{"date":"2024-10-18","current":-0.661972,"twenty":-10.913337,"median":-2.027788,"eighty":-0.618966,"marketCap":40564968},{"date":"2024-10-25","current":-0.616319,"twenty":-10.822012,"median":-2.005736,"eighty":-0.617173,"marketCap":37767384},{"date":"2024-10-31","current":-0.616319,"twenty":-10.764934,"median":-1.98954,"eighty":-0.617173,"marketCap":37767384},{"date":"2024-11-08","current":-0.602623,"twenty":-10.621175,"median":-1.977767,"eighty":-0.616319,"marketCap":36928108},{"date":"2024-11-15","current":-0.640617,"twenty":-10.582284,"median":-1.960778,"eighty":-0.616319,"marketCap":37487625},{"date":"2024-11-22","current":-0.617393,"twenty":-10.508965,"median":-1.933817,"eighty":-0.616319,"marketCap":36128622},{"date":"2024-11-29","current":-0.559961,"twenty":-10.470905,"median":-1.905849,"eighty":-0.612684,"marketCap":32767820},{"date":"2024-12-06","current":-0.521673,"twenty":-10.415615,"median":-1.89048,"eighty":-0.609811,"marketCap":30527285},{"date":"2024-12-13","current":-0.521673,"twenty":-10.270434,"median":-1.848889,"eighty":-0.607188,"marketCap":30527285},{"date":"2024-12-20","current":-0.454669,"twenty":-10.143923,"median":-1.824428,"eighty":-0.604996,"marketCap":26606349},{"date":"2024-12-27","current":-0.396185,"twenty":-10.050315,"median":-1.805541,"eighty":-0.602075,"marketCap":23183933},{"date":"2025-01-03","current":-0.393409,"twenty":-9.932137,"median":-1.794209,"eighty":-0.601294,"marketCap":23021494},{"date":"2025-01-10","current":-0.407288,"twenty":-9.818652,"median":-1.777211,"eighty":-0.600815,"marketCap":23833688},{"date":"2025-01-17","current":-0.366607,"twenty":-9.72937,"median":-1.735661,"eighty":-0.598057,"marketCap":21453119},{"date":"2025-01-24","current":-0.410638,"twenty":-9.543598,"median":-1.712997,"eighty":-0.59464,"marketCap":24029734},{"date":"2025-01-31","current":-0.382401,"twenty":-9.475453,"median":-1.703555,"eighty":-0.59153,"marketCap":22377340},{"date":"2025-02-07","current":-0.378094,"twenty":-9.382261,"median":-1.696,"eighty":-0.587316,"marketCap":22125280},{"date":"2025-02-14","current":-0.346793,"twenty":-9.348751,"median":-1.663442,"eighty":-0.58313,"marketCap":20293643},{"date":"2025-02-21","current":-0.359428,"twenty":-9.263694,"median":-1.646895,"eighty":-0.580377,"marketCap":21033019},{"date":"2025-02-28","current":-0.368043,"twenty":-9.078223,"median":-1.623756,"eighty":-0.579114,"marketCap":21537139},{"date":"2025-03-07","current":-0.341194,"twenty":-8.986591,"median":-1.61447,"eighty":-0.575321,"marketCap":19965965},{"date":"2025-03-14","current":-0.362325,"twenty":-8.893686,"median":-1.569098,"eighty":-0.574813,"marketCap":20164812},{"date":"2025-03-21","current":-0.309184,"twenty":-8.741312,"median":-1.507136,"eighty":-0.570766,"marketCap":17207306},{"date":"2025-03-28","current":-0.267063,"twenty":-8.611093,"median":-1.463232,"eighty":-0.568625,"marketCap":14863147},{"date":"2025-04-04","current":-0.199782,"twenty":-8.476684,"median":-1.440546,"eighty":-0.565874,"marketCap":11118653},{"date":"2025-04-11","current":-0.135872,"twenty":-7.959595,"median":-1.420259,"eighty":-0.561581,"marketCap":7561804},{"date":"2025-04-17","current":-0.168481,"twenty":-7.569005,"median":-1.371154,"eighty":-0.560181,"marketCap":9376637},{"date":"2025-04-25","current":-0.210853,"twenty":-7.344302,"median":-1.337158,"eighty":-0.559654,"marketCap":11734800},{"date":"2025-05-02","current":-0.24155,"twenty":-7.11206,"median":-1.276722,"eighty":-0.557475,"marketCap":13443208},{"date":"2025-05-09","current":-0.217729,"twenty":-6.877785,"median":-1.134288,"eighty":-0.555287,"marketCap":10782573},{"date":"2025-05-16","current":-0.23336,"twenty":-6.545868,"median":-1.070012,"eighty":-0.553759,"marketCap":11556678},{"date":"2025-05-23","current":-0.281561,"twenty":-3.703039,"median":-1.051107,"eighty":-0.550181,"marketCap":13943749},{"date":"2025-05-30","current":-0.281165,"twenty":-3.644191,"median":-1.027629,"eighty":-0.549404,"marketCap":13924114},{"date":"2025-06-06","current":-0.280655,"twenty":-3.614328,"median":-0.99204,"eighty":-0.545892,"marketCap":13898869},{"date":"2025-06-13","current":-0.368335,"twenty":-3.59237,"median":-0.956583,"eighty":-0.542337,"marketCap":18241039},{"date":"2025-06-20","current":-0.256356,"twenty":-3.57483,"median":-0.939569,"eighty":-0.54061,"marketCap":12695516},{"date":"2025-06-27","current":-0.260547,"twenty":-3.545774,"median":-0.894462,"eighty":-0.536302,"marketCap":12903087},{"date":"2025-07-03","current":-0.24684,"twenty":-3.530008,"median":-0.849684,"eighty":-0.53175,"marketCap":12224273},{"date":"2025-07-11","current":-0.265192,"twenty":-3.51332,"median":-0.810837,"eighty":-0.528292,"marketCap":13133099},{"date":"2025-07-18","current":-0.242139,"twenty":-3.491362,"median":-0.74804,"eighty":-0.526798,"marketCap":11991446},{"date":"2025-07-25","current":-0.248275,"twenty":-3.472038,"median":-0.736291,"eighty":-0.52374,"marketCap":12295323},{"date":"2025-08-01","current":-0.268031,"twenty":-3.449479,"median":-0.731713,"eighty":-0.523533,"marketCap":13273713},{"date":"2025-08-08","current":-0.275326,"twenty":-3.419147,"median":-0.729434,"eighty":-0.521673,"marketCap":13634994},{"date":"2025-08-15","current":-0.226104,"twenty":-3.369274,"median":-0.724196,"eighty":-0.519376,"marketCap":13775811},{"date":"2025-08-22","current":-0.224448,"twenty":-3.275977,"median":-0.720564,"eighty":-0.512543,"marketCap":13674922},{"date":"2025-08-29","current":-0.225326,"twenty":-3.23705,"median":-0.71609,"eighty":-0.510764,"marketCap":13728444},{"date":"2025-09-05","current":-0.216981,"twenty":-3.183644,"median":-0.713441,"eighty":-0.507869,"marketCap":13219983},{"date":"2025-09-12","current":-0.238942,"twenty":-3.171159,"median":-0.710254,"eighty":-0.502633,"marketCap":14558038},{"date":"2025-09-19","current":-0.248456,"twenty":-3.161988,"median":-0.708059,"eighty":-0.500566,"marketCap":15137683},{"date":"2025-09-26","current":-0.253876,"twenty":-3.144524,"median":-0.703851,"eighty":-0.497995,"marketCap":15467915},{"date":"2025-10-03","current":-0.252699,"twenty":-3.117868,"median":-0.702251,"eighty":-0.496147,"marketCap":15396196},{"date":"2025-10-10","current":-0.286819,"twenty":-3.087926,"median":-0.700124,"eighty":-0.489482,"marketCap":17474998},{"date":"2025-10-17","current":-0.382132,"twenty":-3.07358,"median":-0.697587,"eighty":-0.489482,"marketCap":23282157},{"date":"2025-10-24","current":-0.390477,"twenty":-3.042328,"median":-0.693548,"eighty":-0.48827,"marketCap":23790617},{"date":"2025-10-31","current":-0.538059,"twenty":-3.00719,"median":-0.691844,"eighty":-0.485279,"marketCap":32782347},{"date":"2025-11-07","current":-0.453007,"twenty":-2.916468,"median":-0.687751,"eighty":-0.483534,"marketCap":26279400},{"date":"2025-11-14","current":-0.450864,"twenty":-2.87069,"median":-0.681733,"eighty":-0.477564,"marketCap":26155062},{"date":"2025-11-21","current":-0.537929,"twenty":-2.83157,"median":-0.679358,"eighty":-0.474718,"marketCap":31205782},{"date":"2025-11-28","current":-0.822955,"twenty":-2.635253,"median":-0.677199,"eighty":-0.474718,"marketCap":47740442},{"date":"2025-12-05","current":-0.743521,"twenty":-2.53274,"median":-0.677199,"eighty":-0.474718,"marketCap":43132422},{"date":"2025-12-12","current":-0.665256,"twenty":-2.5124,"median":-0.674514,"eighty":-0.474718,"marketCap":38592167},{"date":"2025-12-19","current":-0.624955,"twenty":-2.467652,"median":-0.673806,"eighty":-0.474718,"marketCap":36254275},{"date":"2025-12-26","current":-0.747026,"twenty":-2.440803,"median":-0.672773,"eighty":-0.474718,"marketCap":43335717},{"date":"2026-01-02","current":-0.857506,"twenty":-2.419649,"median":-0.672773,"eighty":-0.474718,"marketCap":49744761},{"date":"2026-01-09","current":-0.821248,"twenty":-2.371647,"median":-0.672773,"eighty":-0.474718,"marketCap":47641389},{"date":"2026-01-16","current":-0.777738,"twenty":-2.345612,"median":-0.672773,"eighty":-0.474718,"marketCap":45117342},{"date":"2026-01-23","current":-0.764443,"twenty":-2.322017,"median":-0.672773,"eighty":-0.474718,"marketCap":44346105},{"date":"2026-01-30","current":-0.629684,"twenty":-2.297609,"median":-0.671527,"eighty":-0.474718,"marketCap":36528570},{"date":"2026-02-06","current":-0.670172,"twenty":-2.226826,"median":-0.670824,"eighty":-0.474718,"marketCap":38877336},{"date":"2026-02-13","current":-0.800097,"twenty":-2.183705,"median":-0.670661,"eighty":-0.474718,"marketCap":46414422},{"date":"2026-02-20","current":-0.86234,"twenty":-2.171501,"median":-0.670661,"eighty":-0.474718,"marketCap":50025211},{"date":"2026-02-27","current":-0.785594,"twenty":-2.105623,"median":-0.670661,"eighty":-0.474718,"marketCap":45573073},{"date":"2026-03-06","current":-0.77109,"twenty":-2.086886,"median":-0.670661,"eighty":-0.474718,"marketCap":44731723},{"date":"2026-03-13","current":-0.861986,"twenty":-2.062478,"median":-0.670661,"eighty":-0.474718,"marketCap":48136743},{"date":"2026-03-20","current":-0.642664,"twenty":-2.044892,"median":-0.670359,"eighty":-0.474718,"marketCap":35888932},{"date":"2026-03-27","current":-0.645852,"twenty":-2.02894,"median":-0.665688,"eighty":-0.474718,"marketCap":36066953},{"date":"2026-04-02","current":-0.671354,"twenty":-2.012928,"median":-0.664592,"eighty":-0.474718,"marketCap":37491117},{"date":"2026-04-10","current":-0.714709,"twenty":-1.991809,"median":-0.664592,"eighty":-0.474718,"marketCap":39912196},{"date":"2026-04-17","current":-0.70132,"twenty":-1.977767,"median":-0.664592,"eighty":-0.474718,"marketCap":39164510},{"date":"2026-04-24","current":-0.790579,"twenty":-1.961584,"median":-0.664253,"eighty":-0.474718,"marketCap":44149084},{"date":"2026-05-01","current":-0.587196,"twenty":-1.935445,"median":-0.661944,"eighty":-0.474718,"marketCap":32791376},{"date":"2026-05-08","current":-0.657634,"twenty":-1.905849,"median":-0.659868,"eighty":-0.474718,"marketCap":36724909},{"date":"2026-05-15","current":-0.67645,"twenty":-1.890357,"median":-0.657959,"eighty":-0.474718,"marketCap":36977438},{"date":"2026-05-22","current":-0.67315,"twenty":-1.848133,"median":-0.65482,"eighty":-0.474718,"marketCap":36797061},{"date":"2026-05-29","current":-0.422369,"twenty":-1.824428,"median":-0.650654,"eighty":-0.472457,"marketCap":23088352},{"date":"2026-06-05","current":-0.210524,"twenty":-1.805136,"median":-0.649291,"eighty":-0.464227,"marketCap":11508100},{"date":"2026-06-12","current":-0.147169,"twenty":-1.788921,"median":-0.646678,"eighty":-0.459349,"marketCap":8044847},{"date":"2026-06-18","current":-0.145372,"twenty":-1.77346,"median":-0.645432,"eighty":-0.454618,"marketCap":7946611},{"date":"2026-06-26","current":-0.109029,"twenty":-1.718664,"median":-0.642772,"eighty":-0.440312,"marketCap":5959958},{"date":"2026-07-02","current":-0.128852,"twenty":-1.711109,"median":-0.642097,"eighty":-0.425954,"marketCap":7043587},{"date":"2026-07-10","current":-0.132156,"twenty":-1.701432,"median":-0.639145,"eighty":-0.422369,"marketCap":7224192},{"date":"2026-07-17","current":-0.407702,"twenty":-1.688445,"median":-0.639145,"eighty":-0.413334,"marketCap":22286632},{"date":"2026-07-24","current":-0.276207,"twenty":-1.658227,"median":-0.636926,"eighty":-0.407702,"marketCap":15098561},{"date":"2026-07-31","current":-0.332373,"twenty":-1.635333,"median":-0.634726,"eighty":-0.39992,"marketCap":18168842},{"date":"2026-08-07","current":-0.369377,"twenty":-1.620454,"median":-0.631496,"eighty":-0.393839,"marketCap":20191616},{"date":"2026-08-14","current":-0.886604,"twenty":-1.590448,"median":-0.630015,"eighty":-0.393839,"marketCap":37900532},{"date":"2026-08-21","current":-0.669236,"twenty":-1.54112,"median":-0.630015,"eighty":-0.393839,"marketCap":28608493},{"date":"2026-08-24","current":-0.673519,"twenty":-1.534632,"median":-0.630015,"eighty":-0.393839,"marketCap":28791588}],"updateTime":1787681588142},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NXTC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651958174","title":"Hansoh Pharma Licenses Oral IL-23 Drug Hs-20118 to Avere in Deal Worth up to USD 2.3 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2651958174","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651958174?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:17","pubTimestamp":1784024254,"startTime":"0","endTime":"0","summary":"Hansoh Pharma licenses oral IL-23 drug HS-20118 to Avere in deal worth up to USD 2.3 billionHansoh Pharma signed an exclusive global license with Avere for oral IL-23 receptor antagonist HS-20118, exc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL4B7g8b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","NXTC","BK1589","BK1583","BK4139","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117125","title":"Nextcure Agrees to Merge with Avere Therapeutics in All-stock Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117125","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651117125?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:01","pubTimestamp":1784023292,"startTime":"0","endTime":"0","summary":"NextCure agrees to merge with Avere Therapeutics in all-stock dealNextCure agreed to merge with privately held Avere Therapeutics in an all-stock deal, with closing expected in 2H 2026.The combined co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL9xBHGQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","SG9999014039.USD","SG9999014013.SGD","IE00BKPKM429.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","BK4112","NDAQ","BCDF","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014021.USD","LU0314104364.USD","BK4139","IE00B3QW5Z07.USD","NXTC","BK4585","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651171177","title":"Hansoh Pharmaceutical - Avere Therapeutics to Merge into Nextcure Under Merger Agreement Signed July 14, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651171177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651171177?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023255,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43F17Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","BK1191","03692","NXTC","BK4139","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651517197","title":"Nextcure - Announces Concurrent $320 Mln Private Placement Led by Fairmount and Hansoh","url":"https://stock-news.laohu8.com/highlight/detail?id=2651517197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651517197?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA2FZD33:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651483171","title":"Nextcure Inc: Combined Company Plans to Operate Under Name Avere Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2651483171","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651483171?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA2FZD33:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651317190","title":"Nextcure - Andrew Cheng to Serve as CEO, President, and Chairman of Combined Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2651317190","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651317190?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA2FZD33:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651217190","title":"Nextcure - Combined Company to Operate as Avere Therapeutics, Trade as Avrx After Merger in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651217190","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651217190?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA2FZD33:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651171974","title":"Nextcure - Stockholders to Own 1.21%, Avere Stockholders 98.79% of Combined Company at Closing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651171974","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651171974?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA2FZD33:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651171950","title":"Nextcure and Avere Therapeutics Announce Merger to Advance Once-weekly Oral Il-23 Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2651171950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651171950?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA2FZD33:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651171183","title":"Nextcure - Stockholders to Receive CVR for 90% of Net Proceeds from Pipeline Monetization for Two Years Post-closing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651171183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651171183?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA2FZD33:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651171134","title":"Nextcure - Avere to Pay Hansoh $120 Mln Upfront, up to $2.18 Bln in Milestones, Plus Royalties for Avr-1 Ex-china Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2651171134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651171134?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA2FZD33:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651935171","title":"Press Release: Nextcure and Avere Therapeutics Announce Merger to Advance Once-weekly Oral IL-23 Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2651935171","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651935171?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023200,"startTime":"0","endTime":"0","summary":"Avere Therapeutics' lead program, AVR-001, is a differentiated oral peptide interleukin-23 (IL-23) receptor antagonist, with Phase 1b psoriasis data supporting its potential to be rapidly developed as","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CVR","BK4161","BK4139","BK4539","NXTC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646309870","title":"Nextcure Shareholders Approve Amended 2019 Incentive Plan Adding 80,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2646309870","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646309870?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:02","pubTimestamp":1782388951,"startTime":"0","endTime":"0","summary":"NextCure shareholders approve amended 2019 incentive plan adding 80,000 sharesNextCure held its annual shareholder meeting on June 18, 2026.Shareholders adopted an amended and restated 2019 Omnibus In","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL6bKdbk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640152426","title":"NextCure posts Phase 1 dose-escalation data for SIM0505 in ovarian, uterine serous cancers at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640152426","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640152426?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:01","pubTimestamp":1780574498,"startTime":"0","endTime":"0","summary":"NextCure flagged replay availability for a virtual KOL event on SIM0505, following presentation of Phase 1 dose-escalation data at ASCO 2026.Results were already presented at ASCO on June 1, 2026, marking the first disclosed clinical efficacy signals for the program.Discussion highlighted early signs of anti-tumor activity in ovarian cancer, uterine serous carcinoma, where treatment options remain limited.SIM0505 is an investigational antibody-drug conjugate targeting Cadherin-6, positioning it as a potential new entrant in gynecologic oncology.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL5lXfrW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU0314104364.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","NXTC","LU2210149790.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014005.SGD","LU2095319765.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","BK4139","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4585","BK4588","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640439152","title":"Nxtc Announces Replay Available for Virtual Kol Event Discussing Asco 2026 Dose Escalation Data From Phase 1 Trial of Sim0505 for Gynecologic Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2640439152","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640439152?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:00","pubTimestamp":1780574402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA8CSHVJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640694507","title":"NextCure posts Phase 1 SIM0505 dose-escalation presentation slides","url":"https://stock-news.laohu8.com/highlight/detail?id=2640694507","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640694507?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:34","pubTimestamp":1780407275,"startTime":"0","endTime":"0","summary":"NextCure published virtual KOL event slides with initial Phase 1 dose-escalation results for SIM0505, a CDH6-targeted antibody-drug conjugate.At therapeutic doses of 4.8-8.0 mg/kg, gynecologic cancers showed a 55% ORR at 12 weeks and best response.Ovarian cancer ORR was 52.9% ; uterine serous carcinoma ORR was 66.7% (2/3).Across 59 patients dosed 1.6-9.6 mg/kg, grade 3 or higher TEAEs occurred in 54.2%; grade 3 or higher TRAEs occurred in 47.5%.Dose optimization started in 2Q 2026, testing 5.6, 6.4, 7.2 mg/kg every three weeks; a pivotal trial in platinum-resistant ovarian cancer is being planned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief on June 02, 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL7tn941:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640144329","title":"NextCure share weakness overdone, says Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2640144329","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640144329?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:10","pubTimestamp":1780395004,"startTime":"0","endTime":"0","summary":"Lucid Capital analyst Christopher Liu says NextCure’s (NXTC) SIM0505 data “were relatively encouraging,” despite the shares trading down 45%. The w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nextcure-share-weakness-overdone-says-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nextcure-share-weakness-overdone-says-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4099","BK4555","LCDL","BK4596","LCIZ","NXTC","BK4139","LCID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917957","title":"NextCure presents Phase 1 data for SIM0505 in gynecologic cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917957?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:49","pubTimestamp":1780321785,"startTime":"0","endTime":"0","summary":"NextCure (NXTC) and Simcere Zaiming Pharmaceutical announced positive Phase 1 dose escalation data for SIM0505, an antibody-drug conjugate targetin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nextcure-presents-phase-1-data-for-sim0505-in-gynecologic-cancers-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nextcure-presents-phase-1-data-for-sim0505-in-gynecologic-cancers-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640515579","title":"NextCure posts corporate presentation highlighting SIM0505 CDH6-targeting ADC program in cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640515579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640515579?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:18","pubTimestamp":1780316338,"startTime":"0","endTime":"0","summary":"NextCure highlighted SIM0505, a CDH6-targeted TOPOi antibody-drug conjugate, as its lead program advancing toward a pivotal study.Phase 1 data showed 55% ORR in gynecologic cancers at therapeutic doses; dose escalation completed; dose optimization initiated.Dose-optimization plan targets 5.6, 6.4, 7.2 mg/kg in PROC and uterine serous carcinoma, enrolling up to 120 patients.Pivotal trial planning outlined for PROC, comparing SIM0505 with treatment of physician’s choice; n=215, expandable to 430; endpoints ORR, PFS.Development strategy includes combining US and China data, expanding sites across North America and Europe, initiating CDMO tech transfer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original con","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL3tvSBw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959092","title":"NextCure reports 55% response rate in Phase 1 SIM0505 trial in gynecologic cancers at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959092","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959092?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:08","pubTimestamp":1780315724,"startTime":"0","endTime":"0","summary":"NextCure reported positive early-stage results for SIM0505, an experimental antibody-drug conjugate for gynecologic cancers, presented at ASCO 2026.The study showed meaningful tumor shrinkage signals in heavily pretreated ovarian cancer and uterine serous carcinoma patients within the targeted dose range.Safety looked manageable overall, supporting continued Phase 1 dose optimization with a strategic focus on platinum-resistant ovarian cancer.A virtual key opinion leader event is scheduled for June 2, 2026 to review the ASCO data.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL4bg3mj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":62,"code":"91000000","status":"200"}]}}